Breaking News
0

Eidos Therapeutics Inc (EIDX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Eidos Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
45.20 +3.00    +7.11%
14/11 - Closed. Currency in USD ( Disclaimer )
Type: Equity
Market: United States
ISIN: US28249H1041 
CUSIP: 28249H104
  • Volume: 178,223
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 41.62 - 45.46
START TRADING NOW
| AD | 75% of retail investor accounts lose money when trading spread bets and CFDs with this provider
Eidos Therapeutics 45.20 +3.00 +7.11%
START TRADING NOW
| AD | 75% of retail investor accounts lose money when trading spread bets and CFDs with this provider

EIDX Overview

 
This is the main Eidos Therapeutics Inc stock chart and current price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close42.2
Day's Range41.62 - 45.46
Revenue26.69M
Open42.38
52 wk Range11.15 - 49.72
EPS - 1.37
Volume178,223
Market Cap1.69B
Dividend (Yield)N/A (N/A)
Average Vol. (3m)167,611
P/E RatioN/A
BetaN/A
1-Year Change228.97%
Shares Outstanding37,496,571
Next Earnings DateApr 20, 2020
What is your sentiment on Eidos Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Eidos Therapeutics Inc News


Midday Gainers / Losers (08/27/2018)
Midday Gainers / Losers (08/27/2018) By Seeking Alpha - Aug 27, 2018

Gainers: TIS +37%. HMNY +37%. CRON +21%. TLRY +20%. ALNY +17%. JMEI +17%. CTXR +18%. LAC +15%. KONE +14%. LEVB +13%. Losers: EIDX -31%. ECR -13%. PTX -11%. GURE -11%. FOSL -9%....

Eidos Therapeutics Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Buy Buy Buy Buy
Technical Indicators Strong Buy Strong Buy Strong Buy Strong Buy Strong Buy
Summary Strong Buy Strong Buy Strong Buy Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Completed Patterns
Bullish doji Star 5H 3 Nov 13, 2019 08:00AM
Doji Star Bearish 30 4 Nov 14, 2019 01:30PM
Doji Star Bearish 1M 5 Jun 19
Doji Star Bearish 15 6 Nov 14, 2019 01:30PM
Advance Block Bearish 1M 7 Apr 19

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 262.64 264.88 262.10 -1.83 -0.69% 22.40M 15:59:59  
  Facebook 193.15 194.03 191.45 -0.04 -0.02% 9.06M 15:59:59  
  Alphabet A 1,309.15 1,315.72 1,293.94 +12.97 +1.00% 1.45M 15:59:59  
  Microsoft 148.06 148.41 147.00 +0.75 +0.51% 19.76M 15:59:59  
  Amazon.com 1,754.60 1,766.59 1,749.56 +1.49 +0.09% 2.27M 15:59:59  
  Exxon Mobil 68.50 68.97 68.18 -0.30 -0.44% 11.28M 14/11  
  NVIDIA 209.79 209.88 206.52 +1.22 +0.58% 13.18M 15:59:59  
  Lockheed Martin 390.16 392.30 387.28 +2.47 +0.64% 915.59K 14/11  
  Alibaba ADR 182.80 184.50 181.32 +0.32 +0.18% 12.75M 14/11  
  Bank of America 32.70 32.86 32.49 -0.09 -0.27% 35.58M 14/11  

Eidos Therapeutics Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

36

Equity Type

ORD

Eidos Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is focused on addressing the unmet need in diseases caused by transthyretin (TTR), amyloidosis (ATTR). It focuses on treating the disease by targeting them at their collective source by stabilizing TTR. The Company’s product candidate, AG10, is an orally-administered small molecule designed to potently stabilize tetrameric TTR, thereby halting at its outset the series of molecular events that give rise to ATTR. AG10 binds and stabilizes TTR in the blood, preventing the formation of amyloid and halting progression of the disease.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $500 Start Trading
Securities Investor Protection Corporation (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EIDX Comments

Write your thoughts about Eidos Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Juan P Gomez
Juan P Gomez Jun 20, 2018 5:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
# 1 here
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email